Immunogen Inc. (Nasdaq:IMGN) a biotechnology company that develops targeted antibody-based anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, announced that the Company will host a conference call at 4:30 p.m. ET on Thursday, January 27, 2011, to discuss ImmunoGen's financial results for the three-month period ended December 31, 2010 – the second quarter of the Company’s 2011 fiscal year. Management also will provide an update on the Company. To access the live call by phone, dial 913-312-0379. Passcode: 7227748. The call also may be accessed through the Investor Information section of the Company's website, http://www.immunogen.com.
ImmunoGen, Inc. engages in the research and development of antibody-based anticancer therapeutics in the United States. The company develops its product candidates using its Targeted Antibody Payload (TAP) technology.
American Video Teleconferencing Corp. (Pink Sheets:AVOT) is pleased to announce that Wayne Lockhart, BSc. Geology, has joined the company as special geological advisor to AVOT for advancing the company’s exploration programs on its newly acquired rare earth property in Quebec.
Mr. Lockhart has over 35 years experience in the mining business having worked for Falconbridge and Phelps Dodge in eastern Canada, Anglo American Corp.(DeBeers) in Africa and Benguet Cons. in the Philippines. Mr. Lockhart in addition to being a lecturer at the University of New Brunswick in Geology, has developed programs for the United Nations (UNDP). Mr. Lockhart is an Honorary Director of the Prospector and Developers Association of Canada (PDAC), a founding and former member of the Association of Exploration Geochemists and a Member of the Society of Economic Geologists.
American Video is looking forward to this new relationship with Mr. Lockhart as he will be able to provide the guidance, expertise and leadership that will be needed moving forward, as he has had many years experience working in the province of Quebec.
The 17 elements that are classified as "rare earth" are becoming an increasingly important part of our daily lives. Rare earth metals are the life blood of modern computers, batteries and alternative energies. For example, there are nearly ten pounds of the rare earth element, lanthanum, in every Toyota Prius engine. In addition, rare earth elements are vital to military technology. Contrary to the name, rare earth metals aren't particularly rare and can be found in most any continent. In recent weeks the US government has made important steps to increase production of these metals, as they will play an important part in President Obama's overhaul of U.S. energy.
American Video will aggressively continue to search world-wide for opportunities in Precious, Base and Rare Earths metal projects.
Power3 Medical Products, Inc. (OTC.BB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, announced that it has signed a definitive agreement to acquire all of the stock of Rozetta-Cell Life Sciences, Inc. Power3 plans to effectuate the acquisition of Rozetta-Cell by merging Rozetta-Cell with and into Power3, with Power3 remaining as the surviving company in the merger. The acquisition of Rozetta-Cell is expected to be completed in February 2011.
Rozetta-Cell is a medical biotechnology company that focuses on the delivery and imaging of stem cells during therapy. The company has a robust intellectual property portfolio and has created numerous products for adult stem cell therapy that are ready for market globally. Rozetta-Cell also has several collaborations in process through which it is partnering with industry-leading adult stem cell research companies and adult stem cell vendors.
“We are very excited to be acquiring Rozetta-Cell Life Sciences,” stated Ira L. Goldknopf, President and Chief Scientific Officer of Power3 Medical Products, Inc. “Rozetta-Cell brings us a tremendous amount of complementary adult stem cell therapy technology, know-how and experience. With the addition of Rozetta-Cell, Power3 will significantly strengthen its IP portfolio in a major growth market by merging regenerative medicine with the technologies that we are using to identify disease-specific protein biomarkers and develop them into screening and diagnostic tests to address unmet medical needs.”
Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease). Power3 applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual’s proteins to detect the presence of disease, a patient’s disease progression, a patient’s response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.
VIST Financial Corp (Nasdaq:VIST) reported net income for the twelve months ended December 31, 2010 of $3,984,000, a $3,377,000 or a 556.3% increase over net income of $607,000 for the same period in 2009. The Company also reported net income for the three months ended December 31, 2010 of $1,347,000, a $918,000 or a 214.0% increase over net income of $429,000 for the same period in 2009. On November 19, 2010, the Company acquired certain assets and assumed certain liabilities of Allegiance Bank of North America ("Allegiance") of Bala Cynwyd, Pennsylvania, through an FDIC-assisted whole bank acquisition. The Allegiance acquisition added five full-service locations in Chester and Philadelphia counties, of which the Company expects to close one by March 31, 2011.
VIST Financial Corp. operates as the holding company for VIST Bank that provides commercial and consumer banking services in Berks, Schuylkill, Philadelphia, Delaware, and Montgomery counties of Pennsylvania.
Wilshire Bancorp Inc. (Nasdaq:WIBC) the holding company for Wilshire State Bank, reported a net loss to common shareholders of $30.0 million, or ($1.02) per basic and diluted share, for the quarter ended December 31, 2010. This compares to net income available to common shareholders of $3.2 million, or $0.11 per basic and diluted common share, for the same period of the prior year. The net loss reported for the fourth quarter of 2010 is attributable to $65.5 million in provision for loan losses that was largely driven by the disposal of a significant number of problem assets through note sales and charge-offs. The fourth quarter 2010 credit management actions had the effect of significantly lowering the risk profile of the Company's loan portfolio and reducing its level of non-accrual; troubled debt restructured (TDRs), classified and impaired loans.
Wilshire Bancorp, Inc. operates as the bank holding company for Wilshire State Bank that offers a range of financial products and services. It accepts various deposit products, including certificates of deposit, regular savings accounts, money market accounts, and individual retirement accounts.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period.
Crown Equity Holdings Inc. (OTCPK:CRWE) has received from the company 2,000,000 shares of (144) restricted common stock of American Video Teleconferencing Corp. (OTC:AVOT) for 12 months IR Services and 1,000,000 shares of (144) restricted common stock for its IT services.
Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (OTC:PWRM).
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.